Abbott Laboratories
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ABL.DE | ABBOTINDIA.NS | BMY | INDSWFTLAB.NS | LLY | MOREPENLAB.NS | |
|---|---|---|---|---|---|---|
| Market cap | 175.03B | 565.34B | 130.07B | 31.52B | 1.24T | 53.21B |
| P/E (TTM) | 43.8 | 35.0 | 14.1 | 37.0 | 45.2 | 28.3 |
| Forward P/E | — | 29.4 | 9.6 | — | 27.8 | — |
| Price/book | 3.8 | 11.8 | 5.6 | 2.1 | 30.8 | 3.9 |
| Dividend yield | 2.29% | 1.94% | 3.93% | — | 0.49% | 0.20% |
| 1-year change | −4.95% | −7.93% | +37.66% | +266.59% | +51.26% | +113.46% |
| Today | −0.93% | −1.90% | −0.87% | −3.72% | −1.75% | −4.17% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All ABL.DE news ›Abbott Laboratories Stock (ABT) Moved Up by 3.67% on Nov 2: A Full Analysis
TradingKey Abbott Laboratories Stock (ABT) Moved Up by 3.67% on Nov 2: A Full Analysis What is driving Abbott Laboratories (ABT)’s stock price up today? Positive clinical data presentations at the Transcatheter Cardiovascul
Top Players Abbott Laboratories, Cepheid, bioMérieux, Roche Diagnostics, and QuidelOrtho in the Point-of-Care Molecular Diagnostics Market as It Reaches USD 15.1 Billion by 2036, Growing at 10.0% CAGR
Top Players Abbott Laboratories, Cepheid, bioMérieux, Roche openPR.com Top Players Abbott Laboratories, Cepheid, bioMérieux, Roche Diagnostics, and QuidelOrtho in the Point-of-Care Molecular Diagnostics Market as It Reaches USD 15.1…
Abbott Laboratories $ABT Stock Acquired by Hollow Brook Wealth Management LLC
Posted by Kim Johansen on Nov 2nd, 2026 The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Thursday, October 15th will be paid a $0.63 dividend. The ex-dividend date is…
Abbott Laboratories to Pay $384 Million Over Infant Formula Contamination Risk Claims
Abbott Laboratories has agreed to pay more than $384 million to settle allegations that it manufactured infant formula under conditions that posed a risk of contamination and then sold the products to federal and state programs, the U.S.…
Abbott Laboratories Starts Trial for Device to Treat Mitral Heart Valve Disease
Abbott Laboratories said Thursday it has started a trial assessing the safety and effectiveness of its investigational Cephea mitral valve system to treat people with mitral valve disease who are... Medical Equipment, Supplies &…
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT) and Taysha Gene Therapies (TSHA) with bullish sentiments. TD Cowen analyst Josh Jennings…
Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT)
In a report released today, Christopher Pasquale from Barclays maintained a Buy rating on Abbott Laboratories, with a price target of $120.00. According to TipRanks, Pasquale is a 4-star analyst with an average return of 9.7% and a 59.56%…
Abbott Laboratories: A New Growth Story Takes Shape
Abbott Laboratories remains a Buy, driven by robust device and diagnostics growth and the strategic spin-off of its Nutrition business. Learn more about ABT stock here. - Abbott Laboratories remains a Buy, driven by robust device and…
Notable healthcare headlines for the week: Moderna, Roche, and Abbott Laboratories in focus
Healthcare stocks outperformed as Wall Street fell. See top healthcare winners and losers, Moderna data fallout, and major pharma deals—read now. Wall Street's major averages finished in the red on Friday as technology stocks continued to…
Abbott Laboratories (ABT) Gets a Buy from Bank of America Securities
Bank of America Securities analyst Travis Steed maintained a Buy rating on Abbott Laboratories yesterday and set a price target of $115.00. The company’s shares closed yesterday at $100.51. According to TipRanks, Steed is a 3-star analyst…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com17
- theglobeandmail.com12
- themarketsdaily.com9
- defenseworld.net6
- openpr.com5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 68 articles, not a forecast.